Lumira Capital's Brent Norton appointed head of Ortho RTI
Ortho Regenerative Technologies Inc (Ortho RTI) has appointed Dr. Brent Norton as its executive chairman and acting CEO. He succeeds Edward Margerrison, who is leaving for a new position. Norton joins Ortho RTI from Canadian life sciences venture capital firm Lumira Capital, where he served as a venture partner. He also worked as a senior executive and director for several life sciences companies. Kirkland, Québec's Ortho RTI is a developer of technology products that treat unmet needs in the orthopaedic market.
18 October 2016•3 mins read
